Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heterochromatin | 4 | 2020 | 16 | 1.190 |
Why?
|
| STAT3 Transcription Factor | 3 | 2020 | 90 | 0.850 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2020 | 58 | 0.760 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 63 | 0.710 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 358 | 0.640 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 85 | 0.580 |
Why?
|
| Gene Expression | 1 | 2018 | 674 | 0.500 |
Why?
|
| Phosphorylation | 6 | 2020 | 928 | 0.390 |
Why?
|
| Cell Line, Tumor | 7 | 2020 | 2231 | 0.330 |
Why?
|
| Signal Transduction | 7 | 2020 | 1908 | 0.330 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 219 | 0.290 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2019 | 222 | 0.260 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 803 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 807 | 0.250 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2020 | 44 | 0.250 |
Why?
|
| Cell Proliferation | 6 | 2020 | 1198 | 0.240 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2020 | 43 | 0.220 |
Why?
|
| Histones | 4 | 2020 | 190 | 0.220 |
Why?
|
| Mice, Nude | 2 | 2020 | 337 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 259 | 0.190 |
Why?
|
| Streptonigrin | 1 | 2020 | 1 | 0.180 |
Why?
|
| Curcumin | 1 | 2020 | 74 | 0.180 |
Why?
|
| Models, Biological | 3 | 2019 | 677 | 0.180 |
Why?
|
| Methotrexate | 1 | 2019 | 23 | 0.170 |
Why?
|
| S100 Proteins | 1 | 2019 | 12 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 45 | 0.170 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 409 | 0.160 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 180 | 0.150 |
Why?
|
| Chromatin | 1 | 2019 | 169 | 0.150 |
Why?
|
| Receptor, erbB-2 | 1 | 2019 | 133 | 0.150 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 90 | 0.150 |
Why?
|
| Withanolides | 1 | 2017 | 9 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 173 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 136 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 88 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 35 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 251 | 0.150 |
Why?
|
| Telomerase | 1 | 2017 | 44 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 219 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 448 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2017 | 153 | 0.140 |
Why?
|
| Drosophila Proteins | 2 | 2019 | 171 | 0.140 |
Why?
|
| Neoplasms | 3 | 2019 | 1103 | 0.140 |
Why?
|
| Humans | 12 | 2021 | 37093 | 0.140 |
Why?
|
| Mice | 5 | 2020 | 5913 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 626 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 356 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1015 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2017 | 339 | 0.120 |
Why?
|
| Ecdysteroids | 1 | 2013 | 2 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2013 | 8 | 0.120 |
Why?
|
| Brain | 1 | 2021 | 1346 | 0.110 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 46 | 0.110 |
Why?
|
| Animals | 7 | 2020 | 15081 | 0.110 |
Why?
|
| Drosophila | 1 | 2013 | 144 | 0.110 |
Why?
|
| Hela Cells | 3 | 2020 | 366 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 441 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 194 | 0.100 |
Why?
|
| Female | 3 | 2020 | 20969 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 186 | 0.100 |
Why?
|
| Carcinoma, Ehrlich Tumor | 2 | 2006 | 19 | 0.090 |
Why?
|
| Doxorubicin | 2 | 2006 | 84 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2019 | 76 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1502 | 0.080 |
Why?
|
| Animals, Genetically Modified | 2 | 2019 | 99 | 0.070 |
Why?
|
| Glycine | 1 | 2006 | 47 | 0.070 |
Why?
|
| Drug Resistance, Multiple | 1 | 2006 | 27 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2006 | 73 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2006 | 57 | 0.070 |
Why?
|
| Copper | 1 | 2006 | 105 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2020 | 366 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 578 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 461 | 0.060 |
Why?
|
| Sirolimus | 1 | 2020 | 60 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 173 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 78 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2019 | 12 | 0.040 |
Why?
|
| Color | 1 | 2019 | 20 | 0.040 |
Why?
|
| Pigmentation | 1 | 2019 | 11 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2019 | 21 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2019 | 38 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 65 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2019 | 68 | 0.040 |
Why?
|
| Eye | 1 | 2019 | 71 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 269 | 0.040 |
Why?
|
| Apoptosis | 1 | 2006 | 1398 | 0.040 |
Why?
|
| Base Sequence | 1 | 2020 | 997 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 601 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 465 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 481 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 935 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2017 | 45 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 131 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2019 | 387 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 357 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2020 | 426 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 859 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2019 | 681 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 17 | 0.030 |
Why?
|
| Homozygote | 1 | 2013 | 77 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 51 | 0.030 |
Why?
|
| Receptors, Steroid | 1 | 2013 | 36 | 0.030 |
Why?
|
| Methylation | 1 | 2013 | 113 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2013 | 93 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 302 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2013 | 435 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 515 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 689 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 972 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 1095 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2006 | 122 | 0.020 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2006 | 48 | 0.020 |
Why?
|
| Catalase | 1 | 2006 | 109 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 111 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2006 | 67 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 155 | 0.020 |
Why?
|
| Spleen | 1 | 2006 | 199 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 234 | 0.020 |
Why?
|
| Cytokines | 1 | 2006 | 602 | 0.010 |
Why?
|
| Male | 1 | 2019 | 20025 | 0.010 |
Why?
|